Effects of lercanidipine and its enantiomers on ischemia and reperfusion

Journal of Cardiovascular Pharmacology

Volumn 29, Issue SUPPL. 1, 1997, Pages

  Cargnoni, A ^a   Benigno, M ^a   Ferrari, F ^a   Pedersini, P ^a   Curello, S ^a   Pepi, P ^a   Ferrari, R ^a  

^a IRCCS   (Italy)

Author keywords

Cardioprotective effects; Enantiomers; Ischemia reperfusion; Lercanidipine

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE; LACTIC ACID; LERCANIDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CORONARY ARTERY DILATATION; DRUG EFFECT; ENANTIOMER; ENZYME ACTIVITY; ENZYME RELEASE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RACEMIC MIXTURE; REPERFUSION; STATISTICAL ANALYSIS;

EID: 0030992671     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199729001-00008     Document Type: Article

References (66)

1. Kloner RA, Braunwald E. Effects of calcium antagonists on infarcting myocardium. Am J Cardiol 1987;59:84B-9B.
2. Klein HH, Schubothe M, Nebendahl K, Kruezer H. The effects of two different diltiazem treatments on infarct size in ischemic reperfused porcine hearts. Circulation 1984;69:1000-5.
3. Melin JA, Becker LC, Hutchins GM. Protective effect of early and late treatment with nifedipine during myocardial infarction in the conscious dog. Circulation 1984;69:131-41.
4. Nayler WG, Ferrari R, Williams A. Protective effect of pretreatment with veraparnil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol 1980;4:242-8.
5. Reimer KA, Jennings RB. Effects of calcium channel blockers on myocardial preservation during experimental acute myocardial infarction. Am J Cardiol 1985;55:107B-15B.
6. Ruigrok TJC, Van Echteld CJA, De Kruijff B, Borst C, Meijler FL. Protective effect of nifedipine in myocardial ischemia assessed by phosphorus-31 nuclear magnetic resonance. Eur Heart J 1983;4(suppl C): 109-13.
7. Smith HJ, Singh BN, Noris RM, Nisbet HD, John MB, Hurley PJ. Effects of veraparnil on infarct size following experimental coronary occlusion. Cardiovasc Res 1975;9:569-78.
8. Braunwald E, Kloner R. The stunned myocardium: prolonged, post-ischemic dysfunction. Circulation 1982;66:1146-9.
9. Crome R, Hearse DJ, Manning AS. Ischemia- and reperfusion-induced arrhythmias: beneficial actions of nifedipine. J Cardiovasc Pharmacol 1986;8:1249-56.
10. Nayler WG, Panogiotopoulos S, Elz JS, Sturrock WJ. Fundamental mechanism of action of calcium antagonist in myocardial ischemia. Am J Cardiol 1987;59:75B-83B.
11. Reimer KA, Jennings RB, Cobb FR, et al. Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study comparison of unconscious and conscious dog model. Circ Res 1985;56:651-5.
12. De Jong JW, Huizer T. Reduced glycolysis by nisoldipine treatment of ischemic heart. J Cardiovasc Pharmacol 1985;7:497-500.
13. Kirkels JH, Ruigrok TJC, Van Echteld CCJA, Meijler FL. Protective effect of pretreatment with the calcium antagonist anipamil on the ischemic-reperfused rat myocardium: a phosphorus-31 nuclear magnetic resonance study. J Am Coll Cardiol 1988;2:1087-93.
14. Lavenchy N, Martin J, Rossi A. Effects of diltiazem on the energy metabolism of the isolated rat heart submitted to ischemia: a role phosphorus-31 nuclear magnetic resonance study. J Mol Cell Cardiol 1986;18:931-41.
15. Drake-Holland AJ, Noble MIM. Myocardial protection by calcium antagonist drugs. Eur Heart J 1983;4:823-5.
16. Chaudhry A, Vohra MM. A reserpine-like action of verapamil on cardiac sympathetic nerves. Eur J Pharmacol 1984;91:156-8.
17. Chaudhry A, Vohra MM. Depletion of cardiac noradrenaline stores by the calcium-channel blocker D-600. Can J Physiol Pharmacol 1984;62:640-4.
18. Higgins AJ, Blackburn KJ. Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists. J Mol Cell Cardiol 1984;16:427-38.
19. Brezinski ME, Darius H, Lefer AM. Cardioprotective action of a new calcium channel blocker in acute myocardial ischemia. Drug Res 1986;36:464-6.
20. Krebs HA, Henseleit K. Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe Seylers Physiol Chem 1932;210: 33-66.
21. Langendorff O. Untersuchungen am überlebenden Saugethierherzen. Pflugers Arch Physiol Mensch Tiere 1895;61:291-332.
22. Oliver TA. A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem J 1955;61:116-22.
23. Ceconi C, Condorelli E, Quinzanini M, Rodella A, Ferrari R, Harris P. Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure. Cardiovasc Res 1989;23:674-82.
24. Noll F. L-(+)-Lactate. In: Bergmeyer HU, ed. Methods of enzymatic analysis. Weinheim: Verlag Chemie, 1984:582-8.
25. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissue. Anal Biochem 1969;27:502-22.
26. Sordhal LA, McCollum WB, Wood WG, Schwartz A. Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failure. Am J Physiol 1973;244:497-502.
27. Williams AJ, Barrie SE. Temperature effects on the kinetics of calcium transport by cardiac mitochondria. Biochem Biophys Res Commun 1978;84:89-93.
28. Bradford MM. A rapid and sensitive method for the qualification of microgram quantities of protein utilizing the principle for protein-dye binding. Anal Biochem 1976;72:248-54.
29. Bernocchi P, Ceconi C, Cargnoni A, Pedersini P, Curello S, Ferrari R. Extraction and assay of crealine phosphate, purine, and pyridine nucleotides in cardiac tissue by reversed-phase high-performance liquid chromatography. Anal Biochem 1994;222:374-9.
30. Peng GF, Rane JJ, Murphy ML, Straub KD. Abnormal mitochondrial oxidative phosphorylation of ischemic myocardium reversed by calcium chelating agents. J Mol Cell Cardiol 1977;9:897-908.
31. Sedlack J, Lindsay RH. Estimation of total, protein-bound and non protein sulphydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192-205.
32. Crapo MD, McCord JM, Fridovich I. Preparation and assay of Superoxide dismutases. In: S Fleischer, L Packer, eds. Methods in enzymology. London: Academic Press, 1977:382-93.
33. Paglia DE, Valentine WN. Studies on the quantittive and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
34. Goldberg DM, Spooner RJ. Glutathione reductase. In: Bergmeyer HU, ed. Methods of enzymatic analysis. Weinheim: Verlag Chemie, 1984;3:258-65.
35. Ferrari R, Cargnoni A, Bernocchi P, et al. Metabolic adaptation during a sequence of no-flow and low-flow ischaemia: a possible trigger for hibernation. Circulation 1996;96:2587-96.
36. Ferrari R, Alfieri O, Curello S, et al. Occurrence of oxidative stress during reperfusion of the human heart. Circulation 1990;81:201-11.
37. Hearse DJ. Stunning: a radical re-view. In: Opie LH, ed. Stunning, hibernation, and calcium in myocardial ischemia and reperfusion. London: Kluwer Academic Publishers, 1992:10-55.
38. Ferrari R, Curello S, Cargnoni A, et al. Metabolic changes during post-ischemic reperfusion. J Mol Cell Cardiol 1988;20: 119-33.
39. Ferrari R, Williams AJ. The role of mitochondria in myocardial damage occurring on post-ischemic reperfusion. J Appl Cardiol 1986;1:501-19.
40. Ferrari R, Curello S, Ceconi C, Di Lisa F, Raddino R, Visioli O. Myocardial recovery during post-ischemic reperfusion: effects of nifedipine, calcium and magnesium. J Mol Cell Cardiol 1986;18:487-98.
41. Neely JR, Whitmer JT, Rovetto MJ. Effect of coronary blood flow on glycolitic flux and intracellular pH in isolated rat hearts. Circ Res 1975;37:733-41.
42. Rovetto MJ, Lamberton WF, Neely JR. Mechanism of glycolytic inhibition in ischemic rat heart. Circ Res 1975;37:742-50.
43. Reibel DK, Rovetto MJ. Myocardial ATP synthesis and mechanical function following oxygen deficiency. Am J Physiol 1978;234:H620-7.
44. Nayler WG. The role of calcium in the ischemic myocardium. Am J Pathol 1981;102:262-70.
45. Jennings RB, Ganote CE. Mitochondrial structure and function in acute myocardial ischemic injury. Circ Res 1976;38: 80-91.
46. Hearse DJ. Reperfusion of the ischemic myocardium. J Mol Cell Cardiol 1977;9:607-16.
47. Henry PD, Schuchleib R, Davis J, Weiss ES, Sobel BE. Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol 1977;233: H677-84.
48. Sperelakis N, Scheneider JA. A metabolic control mechanism for calcium ion influx that may protect the ventricular myocardial cell. Am J Cardiol 1976;37:1079-86.
49. Bourdillon PDV, Poole-Wilson PA. Effects of ischemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium. Cardiovasc Res 1981;15:121-9.
50. Bourdillon PDV, Poole-Wilson PA. The effects of verapamil, quiescence and cardioplegia on calcium exchange and mechanical function in ischemic rabbit myocardium. Circ Res 1982;50:360-8.
51. Ferrari R, Boffa GM, Ceconi C, et al. Effect of D-600 on ischemic and reperfused rabbit myocardium: relation with timing and modality of administration. Basic Res Cardiol 1989;84: 606-12.
52. Henry PD, Wahl AM. Diltiazem and nitrendipine suppress hypoxic contracture in quiescent ventricular myocardium. Eur Heart J 1983;4:819-22.
53. Holt WW, Windland MF, Deruicn N, Wolfe C, Saeed M, Higgins CB. Effects of nicardipine, a calcium antagonist, on myocardial salvage and high energy phosphate stores in reperfused myocardial injury. J Am Coll Cardiol 1990;16:1736-44.
54. Golothwait DA. Mechanisms of synthesis of purine nucleotides in heart muscle extracts. J Clin Invest 1957;36:1572-8.
55. Zimmer HG, Trendelenburg C, Kammermeier H, Gerlach E. De novo synthesis of myocardial adenosine nucleotide in the rat. Circ Res 1973;32:635-9.
56. De Jong JW, Huizer T, Tijssen JGP. Energy conservation by nisoldipine in ischaemic heart. Br J Pharmacol 1984;83:943-9.
57. Weishaar RE, Bing RJ. The beneficial effect of a calcium channel blocker, diltiazem, on the ischemic-reperfused heart. J Mol Cell Cardiol 1980;12:933-1009.
58. Sperelakis N. Cyclic AMP and phosphorylation in regulation of Ca influx into myocardial cells, and blockade by calcium antagonist drugs. Am Heart J 1984;107:347-57.
59. Ferrari R, Ceconi C, Curello S, et al. Oxygen mediated myocardial damage during ischemia and reperfusion: role of the cellular defences against oxygen toxicity. J Mol Cell Cardial 1985;17:937-45.
60. Flohe L, Azzi A, Loschen G, Righter C. Superoxide radicals in mitochondria. In: Michelson AM, McCord JM, Fridovich I, eds. Superoxide and Superoxide dismutase. London: Academic Press, 1977:323-34.
61. Nohl H, Hegner D. Do mitochondria produce oxygen radicals in vivo? Eur J Biochem 1978;82:563-7.
62. Freeman BA, Crapo MD. Biology of disease. Free radicals and tissue injury. Lab Invest 1982;47:412-26.
63. Turrens JF, Freeman BA, Levitt JG, Crapo JD. The effects of hyperoxia on Superoxide production by lung submitochondrial particles. Arch Biochem Biophys 1982;217:401-4.
64. Schaper W, Lewi P, Flameng W, Gijpen L. Myocardial steal provided by coronary artery occlusion. Basic Res Cardiol 1973;68:3-20.
65. Opie LH. Calcium channel antagonists, part I: fundamental properties: mechanisms, classification, sites of action. Cardiovasc Drugs Ther 1987;1:411-30.
66. Bush LR, Li Y-P, Shlafer M, Jolly SR, Lucchesi BR. Protective effects of diltiazem during myocardial ischemia in isolated cat hearts. J Pharmacol Exp Ther 1981;218:653-61.